ALERTEC (modafinil) recall in Canada: Risk of congenital anomalies
In plain language
This recall involves ALERTEC (modafinil) 100 mg tablets and all generic modafinil 100 mg tablets sold in Canada. It's being recalled because it has been linked to major birth defects when used during pregnancy. Stop using the product and follow the return/repair steps in the official notice.
What to do
- Stop using the product immediately.
- Women who are pregnant or may become pregnant should not use ALERTEC.
- Talk to a healthcare professional about birth control methods if you are taking ALERTEC.
- Take a pregnancy test within a week before starting ALERTEC treatment.
- Inform your healthcare professional if you experience any adverse reactions.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
ALERTEC (modafinil) 100 mg tablets
Model: DIN 02239665
All generic modafinil 100 mg tablets
Why this matters
Risk of congenital anomalies
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the model number
Model numbers are typically on the product label or packaging.
Affected models: DIN 02239665
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Risk of congenital anomalies
What should consumers do?
Stop using the product immediately. Women who are pregnant or may become pregnant should not use ALERTEC. Talk to a healthcare professional about birth control methods if you are taking ALERTEC. Take a pregnancy test within a week before starting ALERTEC treatment. Inform your healthcare professional if you experience any adverse reactions.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Risk of congenital anomalies
When was this product recalled?
This product was recalled on June 20, 2019.
Is the ALERTEC brand affected by this recall?
Yes, ALERTEC products are affected by this recall. This recall involves ALERTEC (modafinil) 100 mg tablets and all generic modafinil 100 mg tablets sold in Canada. It's being recalled because it has been linked to major birth defects when used during pregnancy. Stop using the product and follow the return/repair steps in the official notice.